A recent jury verdict in a talc-related lawsuit involving Johnson & Johnson has renewed focus on the legal, financial, and reputational risks faced by large consumer health companies. The ruling is part of a broader wave of litigation tied to legacy talc products, with plaintiffs alleging serious health impacts. While Johnson & Johnson continues to dispute the claims and challenges the scientific evidence presented in court, the verdict underscores the uncertainty surrounding mass tort cases.